Advertisement

Mass Vaccination for Annual and Pandemic Influenza

Chapter
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 304)

Abstract

Influenza virus causes annual epidemics and occasional pandemics. Frequent mutations in circulating influenza strains (“antigenic drift”) result in the need for annual vaccination. More than two-thirds of persons in the U.S. are recommended for annual vaccination. Because influenza vaccine is available seasonally, mass vaccination strategies are well suited to its delivery. Although doctors offices are the most frequent setting for influenza vaccination overall, workplaces, clinics, and community sites (retail stores and pharmacies) also are common vaccination settings. Influenza vaccination also is delivered in mass vaccination clinics to health care workers and military personnel. Universal influenza vaccination, which has been recommended as a strategy to improve prevention by increasing vaccination coverage and providing indirect protection of adults by decreasing infection and transmission among children, would require expanded use of mass vaccination, for example in schools, as well as in the community. Influenza pandemics occur when a new influenza A subtype is introduced into the population (“antigenic shift”). Most or all of the population is susceptible to the pandemic virus and two doses of vaccine may be needed for protection. U.S. pandemic preparedness and response plans indicate that the entire population should be vaccinated beginning with defined priority groups including those who provide essential services including healthcare and those at highest risk of severe illness and death. Pandemic influenza vaccination will occur primarily through the public sector in mass clinic settings. Vaccination program planning must consider issues including coordination, staffing, clinic location and lay-out, security, record keeping, and communications. Exercising vaccination clinics is important for preparedness and can be done in the context of annual influenza vaccination.

Keywords

Influenza Vaccination Vaccination Program Vaccination Coverage Mass Vaccination Priority Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Belshe RB, Newman FK, Cannon J, et al. (2004) Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351:2286–2294PubMedCrossRefGoogle Scholar
  2. Bridges CB, Thompson WW, Meltzer MI, et al. (2000) Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000 284:1655–1663PubMedCrossRefGoogle Scholar
  3. Broder KR, MacNeil A, Malone S (2005) Who’s calling the shots? Pediatricians’ adherence to the 2001–2003 Pneumococcal Conjugate Vaccine Shortage Recommendations. Pediatrics (in press)Google Scholar
  4. CDC (1968) Recommendations of the Public Health Service Advisory Committee on Immunization Practices: A2 influenza virus vaccine, monovalent, 1968–69. MMWR 17:368Google Scholar
  5. CDC (1968a) Recommendations of the Public Health Service Advisory Committee on Immunization Practices: influenza vaccines — 1968–69. MMWR 17:246–247Google Scholar
  6. CDC (2000) Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation: a report of the National Vaccine Advisory Committee. MMWR 49(RR-01)1–13Google Scholar
  7. CDC (2004a) Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices. MMWR 53(RR-06):1–40Google Scholar
  8. CDC (2004b) Estimated influenza vaccination coverage among adults and children — United States, September 1–November 30, 2004Google Scholar
  9. CDC (2004c) Maxi-Vac 1.0 http://www.bt.cdc.gov/agent/smallpox/vaccination/maxivac/index.asp (accessed 12/17/2004)Google Scholar
  10. D’Heilly SJ, Nichol KL (2004) Work site-based influenza vaccination in healthcare and non-healthcare settings. Infect Control Hosp Epidemiol 25:941–945PubMedCrossRefGoogle Scholar
  11. Earhart KC, Beadle C, Miller LK, et al. (2001) Outbreak of influenza in a highly vaccinated crew of U.S. navy ship. Emerg Infect Dis 7:463–465PubMedGoogle Scholar
  12. Gaglani MJ, Piedra PA, Herschler GB, et al. (2004) Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000–2001 influenza A (H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med 158:65–73PubMedCrossRefGoogle Scholar
  13. Glenn GM, Kenney RT, Hammond SA, Ellingsworth LR (2003) Transcutaneous immunization and immunostimulant strategies. ImmunolAllergy Clin N Am 23:787–813CrossRefGoogle Scholar
  14. Glezen PW (2004) Control of influenza. Tex Heart Inst J 31:39–41PubMedGoogle Scholar
  15. Grabenstein JD, Guess HA, Hartzema AG (2001) People vaccinated by pharmacists: descriptive epidemiology. J Am Pharm Assoc 41:46–52Google Scholar
  16. Gray GC, Callahan JD, Hawksworth AW, Fisher CA, Gaydos JC (1999) Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis 5:379–385PubMedCrossRefGoogle Scholar
  17. Hehme N. Engelmann H. Kunzel W. Neumeier E. Sanger R (2002) Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines. Med Microbiol Immunol 191:203–208PubMedCrossRefGoogle Scholar
  18. Hupert N, Cuomo J (2003) Bioterrorism and Epidemic Outbreak Response Model (BERM). DHHS Agency for Healthcare Research and Quality (AHRQ). Available at http://www.ahrq.gov/news/press/pr2003/btmodpr.htm (accessed 12/17/2004)Google Scholar
  19. Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM (2004) Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 351:2295–2301PubMedCrossRefGoogle Scholar
  20. McArthur MA, Simor AE, Campbell B, McGeer A (1999) Influenza vaccination in long-term-care facilities: structuring programs for success. Infect Control Hosp Epidemiol 20:499–503PubMedCrossRefGoogle Scholar
  21. Monto AS, Davenport FM, Napier JA, Francis T Jr. (1969) Effect of vaccination of a school-age population upon the course of an A2/Hong Kong influenza epidemic. Bull World Health Org 41:537–542PubMedGoogle Scholar
  22. National Foundation for Infectious Diseases (2003) Increasing influenza immunization rates in infants and children: putting recommendations into practice. http://www.nfid.org/publications/pediatricflu.pdf (accessed 2/7/05)Google Scholar
  23. Neustadt RE, Feinberg HV (1978) The Swine Flu Affair: Decision-Making on a Slippery Slope. Government Printing Office, Washington DC pp 1–189Google Scholar
  24. Neuzil KM, Hohlbein C, Zhu Y (2002) Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism, and secondary illness in families. Arch Pediatr Adolesc Med 156:986–991PubMedGoogle Scholar
  25. Nichol KL, Lind A, Margolis KL, et al. (1995) The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 333:889–893PubMedCrossRefGoogle Scholar
  26. Parry MF, Grant B, Iton A, Parry PD, Baranowsky D (2004) Influenza vaccination: a collaborative effort to improve the health of the community. Infect Control Hosp Epidemiol 25:929–932PubMedCrossRefGoogle Scholar
  27. Principi N, Esposito S, Gasparini R, Marchisio P, Crovari P (2004) Burden of influenza in healthy children and their households. Arch Dis Child 89:1002–1007PubMedCrossRefGoogle Scholar
  28. Richert TA, Sugaya N, Fesdon DS, Glezen PW, Simonsen L, Tashiro M (2001) The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344:889–896CrossRefGoogle Scholar
  29. Salgado CD, Giannetta ET, Hayden FG, Farr BM (2004) Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol 25:923–928PubMedCrossRefGoogle Scholar
  30. Sartor C, Tissot-Dupont H, Zandotti C, Martin F, Roques P, Drancourt M (2004) Use of a mobile cart influenza program for vaccination of hospital employees. Infect Control Hosp Epidemiol 25:918–922PubMedCrossRefGoogle Scholar
  31. Szilagyi PG, Iwane MK, Humiston, et al. (2003b) Time spent by primary care practices on pediatric influenza vaccination visits: implications for universal influenza vaccination. Arch Pediatr Adolesc Med 157:191–195PubMedGoogle Scholar
  32. Szilagyi PG, Iwane MK, Schaffer S, et al. (2003a) Potential burden of universal influenza vaccination of young children on visits to primary care practices. Pediatrics 112:821–828PubMedCrossRefGoogle Scholar
  33. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K (2004) Influenza-associated hospitalizations in the United States. JAMA 292:1333–1340PubMedCrossRefGoogle Scholar
  34. Thompson WW, Shay DK, Weintraub L, Cox N, Alderson LJ, Fukuda K (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179–186PubMedCrossRefGoogle Scholar
  35. US Department of Health and Human Services (2005) http://www.hhs.gov/nvpo/pan demicplan/ (accessed 2/7/05)Google Scholar
  36. Weycker D, Edelsberg J, Halloran ME, et al. (2005) Population-wide benefits of routine vaccination of children against influenza. Vaccine (in press)Google Scholar
  37. influenza/en/ (accessed 2/7/05)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  1. 1.Immunization Services Division, National Immunization ProgramCenters for Disease Control and PreventionAtlantaUSA

Personalised recommendations